Wellington Management Group LLP Purchases Shares of 10,389,040 Nutrien Ltd. $NTR

Key Points

• Wellington Management bought 10.39 million Nutrien shares worth approximately $654.1 million, giving it a 2.17% stake. Institutional investors collectively own 63.1% of the company.
• Analysts maintain a generally positive view, with Nutrien holding a “Moderate Buy” consensus rating and an average price target of $81.58, above its reported $73.64 share price.
• Nutrien reported quarterly revenue of $10.81 billion, up 3.6% year over year, but earnings per share of $2.61 fell short of estimates. The company declared a quarterly dividend of $0.55 per share, representing a 3.0% yield.

Wellington Management Group LLP purchased a new stake in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 10,389,040 shares of the company's stock, valued at approximately $654,081,000. Wellington Management Group LLP owned about 2.17% of Nutrien at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Montag A & Associates Inc. increased its position in shares of Nutrien by 310.7% in the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company's stock worth $26,000 after purchasing an additional 320 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its holdings in shares of Nutrien by 1,014.0% during the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 479 shares of the company's stock worth $30,000 after acquiring an additional 436 shares during the last quarter. Global Retirement Partners LLC purchased a new position in Nutrien in the second quarter worth $30,000. Evolution Wealth Management Inc. purchased a new position in Nutrien in the first quarter worth $32,000. Finally, Allied Private Wealth LLC bought a new position in Nutrien in the second quarter valued at $33,000. Hedge funds and other institutional investors own 63.10% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on NTR shares. National Bank Financial lowered their price target on Nutrien from $76.00 to $74.00 and set an "outperform" rating on the stock in a research report on Monday, August 10th. UBS Group reduced their price objective on Nutrien from $67.00 to $65.00 and set a "sell" rating on the stock in a research report on Monday, May 11th. Oppenheimer decreased their price objective on Nutrien from $82.00 to $80.00 and set an "outperform" rating on the stock in a report on Thursday, July 23rd. Wall Street Zen downgraded Nutrien from a "buy" rating to a "hold" rating in a research report on Saturday, May 16th. Finally, BNP Paribas Exane upgraded Nutrien from a "neutral" rating to an "outperform" rating and set a $80.00 target price for the company in a research report on Tuesday, July 28th. Seventeen investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, Nutrien presently has an average rating of "Moderate Buy" and a consensus price target of $81.58.

Nutrien Price Performance

Shares of NYSE:NTR opened at $73.64 on Friday. The stock has a market cap of $35.23 billion, a PE ratio of 14.91, a PEG ratio of 0.78 and a beta of 0.61. The company's fifty day moving average is $67.33 and its 200 day moving average is $70.56. Nutrien Ltd. has a 52 week low of $53.03 and a 52 week high of $85.36. The company has a quick ratio of 0.86, a current ratio of 1.39 and a debt-to-equity ratio of 0.36.

Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The company reported $2.61 earnings per share for the quarter, missing the consensus estimate of $2.70 by ($0.09). Nutrien had a return on equity of 8.88% and a net margin of 8.44%.The business had revenue of $10.81 billion during the quarter, compared to the consensus estimate of $10.44 billion. During the same period in the prior year, the firm earned $2.65 earnings per share. The business's revenue for the quarter was up 3.6% on a year-over-year basis. Research analysts anticipate that Nutrien Ltd. will post 4.71 earnings per share for the current year.

Nutrien Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 16th. Investors of record on Tuesday, September 29th will be given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 3.0%. The ex-dividend date is Tuesday, September 29th. Nutrien's dividend payout ratio (DPR) is presently 44.53%.

Nutrien News Roundup

Here are the key news stories impacting Nutrien this week:

• Positive Sentiment: Zacks Research raised its FY2027 EPS estimate to $4.38 from $3.66, a substantial improvement that suggests stronger expected profitability. The firm also lifted estimates for Q2 2027, Q4 2027, FY2026, FY2028, Q1 2027, Q3 2027, Q4 2026 and Q2 2028. Collectively, the revisions point to improving longer-term earnings expectations.
• Positive Sentiment: An investor article emphasizes the appeal of not missing another year of Nutrien’s dividend income, which may reinforce the stock’s attraction to income-oriented investors. You’ve Already Missed a Year of Dividends: Here’s Why I Wouldn’t Miss Another
• Neutral Sentiment: Nutrien’s estimated current-year EPS remains below the broader consensus at $4.71 versus $4.95, while FY2027 and FY2028 estimates are $4.38 and $4.23, respectively. This indicates improving expectations but not an across-the-board bullish outlook.
• Negative Sentiment: Zacks Research reduced its Q3 2026 EPS estimate to $0.78 from $0.92 and its Q1 2028 estimate to $0.63 from $0.76. These cuts signal potential near-term earnings pressure and could limit the stock’s upside.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source